{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:18:32Z","timestamp":1783358312987,"version":"3.54.6"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Henan Province science and technology research project","award":["252102311178"],"award-info":[{"award-number":["252102311178"]}]},{"name":"the Henan Province science and technology research project","award":["242102310121"],"award-info":[{"award-number":["242102310121"]}]},{"name":"the Zhengzhou Science and Technology Innovation Project","award":["2025YLZDJH275"],"award-info":[{"award-number":["2025YLZDJH275"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05114-w","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T13:37:25Z","timestamp":1778593045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pan-cancer investigation identifies ARL4A as a prospective therapeutic indicator for thyroid cancer"],"prefix":"10.1007","volume":"17","author":[{"given":"Yingli","family":"Men","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jizhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaorui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinsen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"key":"5114_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, et al. Cancer statistics, 2025. CA: A Cancer. J Clin. 2025;75:10\u201345.","journal-title":"J Clin"},{"key":"5114_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/S1534-5807(02)00268-X","volume":"3","author":"E Manser","year":"2002","unstructured":"Manser E. Small GTPases take the stage. Dev Cell. 2002;3:323\u20138.","journal-title":"Dev Cell"},{"key":"5114_CR3","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1042\/BST20201059","volume":"49","author":"M Sorbara","year":"2021","unstructured":"Sorbara M, Bery N. Targeting small GTPases and their downstream pathways with intracellular macromolecule binders to define alternative therapeutic strategies in cancer. Biochem Soc Trans. 2021;49:2021\u201335.","journal-title":"Biochem Soc Trans"},{"key":"5114_CR4","doi-asserted-by":"publisher","first-page":"2200214","DOI":"10.1002\/bies.202200214","volume":"45","author":"FL Li","year":"2023","unstructured":"Li FL, Guan KL. The Arf family GTPases: regulation of vesicle biogenesis and beyond. BioEssays. 2023;45:2200214.","journal-title":"BioEssays"},{"key":"5114_CR5","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41420-024-01994-5","volume":"10","author":"H Wu","year":"2024","unstructured":"Wu H, Lu A, Yuan J, et al. Mono-ADP-ribosylation, a MARylationmultifaced modification of protein, DNA and RNA: characterizations, functions and mechanisms. Cell Death Discovery. 2024;10:226.","journal-title":"Cell Death Discovery"},{"key":"5114_CR6","doi-asserted-by":"publisher","first-page":"102347","DOI":"10.1016\/j.arr.2024.102347","volume":"98","author":"W Hao","year":"2024","unstructured":"Hao W, et al. ADP-ribosylation, a multifaceted modification: Functions and mechanisms in aging and aging-related diseases. Ageing Res Rev. 2024;98:102347.","journal-title":"Ageing Res Rev"},{"key":"5114_CR7","doi-asserted-by":"publisher","first-page":"1350097","DOI":"10.3389\/fcell.2024.1350097","volume":"12","author":"A Ferreira","year":"2024","unstructured":"Ferreira A, Castanheira P, Escrevente C, et al. Membrane trafficking alterations in breast cancer progression. Front Cell Dev Biol. 2024;12:1350097.","journal-title":"Front Cell Dev Biol"},{"key":"5114_CR8","doi-asserted-by":"publisher","first-page":"941356","DOI":"10.3389\/fcell.2022.941356","volume":"10","author":"P Li","year":"2022","unstructured":"Li P, Lei Y, Qi J, et al. Functional roles of ADP-ribosylation writers, readers and erasers. Front Cell Dev Biol. 2022;10:941356.","journal-title":"Front Cell Dev Biol"},{"key":"5114_CR9","doi-asserted-by":"publisher","first-page":"7859","DOI":"10.1038\/s41467-023-42979-9","volume":"14","author":"SJ Lin","year":"2023","unstructured":"Lin SJ, Lin MC, Liu TJ, et al. Endosomal Arl4A attenuates EGFR degradation by binding to the ESCRT-II component VPS36. Nat Commun. 2023;14:7859.","journal-title":"Nat Commun"},{"key":"5114_CR10","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3389\/fcell.2020.00217","volume":"8","author":"C Casalou","year":"2020","unstructured":"Casalou C, Ferreira A, Barral DC. The role of ARF family proteins and their regulators and effectors in cancer progression: a therapeutic perspective. Front Cell Dev Biol. 2020;8:217.","journal-title":"Front Cell Dev Biol"},{"key":"5114_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3892\/ol.2024.14413","volume":"27","author":"L Yang","year":"2024","unstructured":"Yang L, Zhang SY, Zheng L, et al. Association of ADP\u2013ribosylation factor family genes with prognosis and immune infiltration of breast cancer. Oncol Lett. 2024;27:280.","journal-title":"Oncol Lett"},{"key":"5114_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.62347\/JEIV8228","volume":"17","author":"X Han","year":"2024","unstructured":"Han X, Liao J, Zhou Y, et al. Thyroid cancer prognostic biomarker ARL4A and its relationship with immune infiltration. Int J Clin Exp Pathol. 2024;17:108\u201320.","journal-title":"Int J Clin Exp Pathol"},{"key":"5114_CR13","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48:W509\u201314.","journal-title":"Nucleic Acids Res"},{"key":"5114_CR14","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47:W556\u201360.","journal-title":"Nucleic Acids Res"},{"key":"5114_CR15","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"key":"5114_CR16","doi-asserted-by":"crossref","unstructured":"Liu CJ, Hu FF, Xie GY et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief Bioinform. 2023. 24:bbac558.","DOI":"10.1093\/bib\/bbac558"},{"key":"5114_CR17","doi-asserted-by":"crossref","unstructured":"Shen W, Song ZG, Zhong X et al. Sangerbox: a comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022. 1: e36.","DOI":"10.1002\/imt2.36"},{"key":"5114_CR18","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"5114_CR19","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","volume":"46","author":"SV Vasaikar","year":"2018","unstructured":"Vasaikar SV, Straub P, Wang J, Zhang B. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46:D956\u201363.","journal-title":"Nucleic Acids Res"},{"key":"5114_CR20","doi-asserted-by":"publisher","first-page":"e2207414119","DOI":"10.1073\/pnas.2207414119","volume":"119","author":"MC Lin","year":"2022","unstructured":"Lin MC, Yu CJ, Lee FJ. Phosphorylation of Arl4A\/D promotes their binding by the HYPK chaperone for their stable recruitment to the plasma membrane. Proc Natl Acad Sci U S A. 2022;119:e2207414119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5114_CR21","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1091\/mbc.E18-01-0001","volume":"30","author":"TS Chiang","year":"2019","unstructured":"Chiang TS, Lin MC, Tsai MC, et al. ADP-ribosylation factor-like 4A interacts with Robo1 to promote cell migration by regulating Cdc42 activation. Mol Biol Cell. 2019;30:69\u201381.","journal-title":"Mol Biol Cell"},{"key":"5114_CR22","doi-asserted-by":"publisher","first-page":"e0274757","DOI":"10.1371\/journal.pone.0274757","volume":"17","author":"N Xie","year":"2022","unstructured":"Xie N, Shu Q, Wang Z, et al. ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members. PLoS ONE. 2022;17:e0274757.","journal-title":"PLoS ONE"},{"key":"5114_CR23","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1038\/onc.2014.402","volume":"34","author":"S Fujii","year":"2015","unstructured":"Fujii S, Matsumoto S, Nojima S, et al. Arl4c expression in colorectal and lung cancers promotes tumorigenesis and may represent a novel therapeutic target. Oncogene. 2015;34:4834\u201344.","journal-title":"Oncogene"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05114-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05114-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05114-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T17:02:20Z","timestamp":1783357340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05114-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5114"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05114-w","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"989"}}